Efficacy and safety of low‐dose imatinib in an elderly patient with mixed phenotype acute leukemia with t(9;22)(q34;q11.2);BCR‐ABL1

Low‐dose imatinib with monitoring of drug concentrations in blood may successfully control Philadelphia chromosome‐positive mixed phenotype acute leukemia (Ph+MPAL), particularly in elderly patients with comorbidities.

Detalles Bibliográficos
Autores principales: Okayama, Yusuke, Takakuwa, Teruhito, Otomaru, Ippei, Horiuchi, Mirei, Miura, Akiko, Araki, Taku, Fujitani, Yotaro, Yamamura, Ryosuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123726/
https://www.ncbi.nlm.nih.gov/pubmed/34026165
http://dx.doi.org/10.1002/ccr3.4126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123726/
https://www.ncbi.nlm.nih.gov/pubmed/34026165
http://dx.doi.org/10.1002/ccr3.4126

Ejemplares similares